secwatch.observer — SEC 8-K summary
======================================

Issuer:     SiriusPoint Ltd (SPNT)
CIK:        0001576018
Form:       8-K
Filed at:   2022-03-01T23:59:59+00:00
Accession:  0001576018-22-000033
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SiriusPoint appoints Jason Robart to board as independent director
------------------------------------------------------------------

- Appointed Jason Robart as independent director effective March 1, 2022; will serve on Audit, Compensation, and Investment Committees.
- Robart is co-founder and managing partner of Seae Ventures, previously Chief Strategy Officer at Blue Cross Blue Shield of Massachusetts.
- With his appointment, SiriusPoint board now has 10 directors; Robart is Class II with term expiring at 2024 annual meeting.
- Compensation will be same as other non-employee directors as described in 2021 proxy statement.
- Chairman and CEO Sid Sankaran noted appointment follows a year of significant transformation and progress.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576018/000157601822000033/0001576018-22-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576018/000157601822000033/tpre-20220224.htm
  HTML page:      https://secwatch.observer/filing/0001576018-22-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer